Hélio Pinczowski
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Colorectal Cancer Treatments and Studies, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer(2023)299 cited
- → Fluconazole versus Amphotericin B in the treatment of Hematogenous Candidiasis: A matched cohort study(1996)187 cited
- → Sorafenib in Combination With Capecitabine: An Oral Regimen for Patients With HER2-Negative Locally Advanced or Metastatic Breast Cancer(2012)161 cited
- → Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01(2024)110 cited
- → Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study(2021)67 cited
- → Gabapentin for the prevention of chemotherapy- induced nausea and vomiting: a pilot study(2011)53 cited
- → SOLTI-0701: A Multinational Double-Blind, Randomized Phase 2b Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo When Administered in Combination with Capecitabine in Patients with Locally Advanced or Metastatic Breast Cancer (BC).(2009)52 cited
- → Tumor lysis syndrome in a case of chronic lymphocytic leukemia induced by high-dose corticosteroids(1997)39 cited
- → Adjunct dipyrone in association with oral morphine for cancer-related pain: the sooner the better(2007)32 cited
- → Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA)(2021)27 cited